Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
adipose tissue-derived stromal cells (Kanazawa University)
- Development stage
- Unknown
- Lead developer
- Kanazawa University
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intra-arterial
01
Overview
Adipose tissue-derived stromal cells (ADSCs) are a population of multipotent mesenchymal stem cells (MSCs) harvested from adipose tissue, which is a richer source of these cells compared to bone marrow. These cells possess the capacity to differentiate into multiple lineages, including myocardium, vascular endothelial cells, and vascular smooth muscle cells, making them a promising candidate for regenerative medicine. In clinical development by **Kanazawa University**, autologous ADSCs are being investigated for the treatment of **ischemic heart failure**. The therapeutic approach involves the intracoronary administration of these cells via cardiac catheterization to promote heart regeneration and improve cardiac function in patients with a reduced ejection fraction (typically < 40%). The mechanism is thought to involve both direct differentiation into cardiac tissues and the secretion of paracrine factors that stimulate angiogenesis and tissue repair.
- Other names
- adipose-derived mesenchymal stem cellsadipose-derived regenerative cellsADRCsadipose-derived stromal cells
Beyond the preview
Go deeper on adipose tissue-derived stromal cells (Kanazawa University).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on adipose tissue-derived stromal cells (Kanazawa University).